Monday, September 12, 2011

Mesothelioma Clinical Trials For Cancer Information

Clinical trials for cancer have garnered much attention over the years. Some who have been afflicted with mesothelioma have found themselves inquiring of more information on the subject. This article will define for you what mesothelioma clinical trials are.

Clinical trials are experimentations of new and innovative cancer treatments conducted for the purpose of medical research. These trials are critically important for cancer patients and in the medical world in an effort to improve health care and advance in the war against cancer. The effects that these new treatments have on patients are watched and documented very closely. Mesothelioma clinical cancer trials are designed to give information about the most effective and safe methods to treat cancer and answer queries of medical professionals.

Participation in these clinical trials means a variety of things for the patient involved. The main benefit that many patients are attracted to is that they are able to receive the treatments before they are made available to the general consuming public, secondly, they are afforded an opportunity to add to society with their contribution to the field of science.

The FDA monitors these studies and permits certain medical professionals to test promising drugs in trials before they are approved for everyday use.

mesothelioma clinical trials for cancer The first phase of clinical trials is to find out the proper dosage amounts that should be prescribed and take note of all potential side effects. This type of treatment is only offered to patients who have widespread cancer and who have not responded positively to standard treatments. These treatments are only offered to a small number of patients because not much is known about the trial treatment at this stage and the risk of side effects may be higher.

In the second phase, this is the stage where some anticancer activity has been found in the new treatment and is being used to treat the cancer to see how well it performs and to take note of the information pertaining to its safety and effectiveness.


Phase three of the mesothelioma clinical trials for cancer is when the comparing and contrasting begin between the standard current treatment and the new treatment.

During this time the physicians are attempting to discover whether this new treatment can be as good or hopefully better than the one that is being used currently. This is where some amazing discoveries have been made in the past.

These types of clinical trials for cancer patients have two or more treatments that are being compared, and each treatment becomes one arm of the study. Each cancer patient is randomly assigned to a particular group by the clinical trial, neither the doctor or the patient is able to influence which group the patient will be assigned to.


It is against the law for a patient to be entered into a clinical trial for cancer without there written consent.

You can find more information about clinical trials by speaking with your physician or by contacting the cancer information service of the National Cancer Institute. You can reach them by calling 1-800-4-CANCER. Various clinical trials for cancer are underway at institutions throughout the United States. Some people find themselves very wary of mesothelioma clinical trials for cancer. They feel as though they don't want to be used as a "guinea pig" for others' research. This is certainly a valid concern. What will help the cancer patient to decide what is best for them is to have a great understanding of what is involved in each clinical trial in order to make an educated decision, fear of the unknown is often worse than the reality.. It is very important to discuss treatment options with your family and your health care provider, but ultimately the final decision is yours.

Leave Clinical Trials For Cancer for Mesothelioma Home





View the original article here

0 comments:

Post a Comment